Oral antiplatelet therapy in PCI patients

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

The use of percutaneous coronary intervention (PCI) in the treatment of obstructive coronary artery disease has expanded rapidly in the past decade. Despite the extensive technological advancements in the field, pharmacotherapy has remained a cornerstone in the overall treatment strategy. Oral antiplatelet therapy has become an essential component of therapy with acute coronary syndromes and in PCI by improving clinical outcomes. This article reviews the antiplatelet options for patients undergoing PCI, including aspirin, ADP receptor blockers, and glycoprotein IIb/IIIa inhibitors.

Original languageEnglish
Pages (from-to)S7-S14
JournalCatheterization and Cardiovascular Interventions
Volume75
Issue numberSUPPL. 1
DOIs
StatePublished - 2010

Keywords

  • Acute coronary syndrome (ACS)
  • Coagulation (COAG)
  • Percutaneous coronary intervention (PCI)
  • Thrombosis (THRM)

Fingerprint

Dive into the research topics of 'Oral antiplatelet therapy in PCI patients'. Together they form a unique fingerprint.

Cite this